Choose the right word

• With the upcoming [patent expiry / drug pricing / payer] , generic manufacturers are preparing entries.
• Senate hearings focused heavily on rising [health technology assessment / drug pricing / rolling submission] in the United States.
• The National Institute for Health and Care Excellence conducted a thorough [health technology assessment / price tag / market launch] in London.
• The calculated [cost per QALY / pivotal trial / regulatory scrutiny] justified the high treatment cost.
• A favorable [reimbursement decision / patent expiry / advisory committee] was issued by the British health authority.
• Merck planned its commercial [market launch / black box warning / surrogate endpoint] for early autumn in Boston.
• The multi-center [pivotal trial / biosimilar / regulatory approval] enrolled over two thousand patients.
• Pfizer opted for a [rolling submission / patent expiry / price tag] to speed up FDA review.
• Intense [regulatory scrutiny / drug pricing / health technology assessment] delayed the drug's approval in Washington.
• Navigating the complex [approval pathway / market launch / pharmacovigilance] requires seasoned regulatory consultants.
• The staggering annual [price tag / patent expiry / rolling submission] sparked fierce debate among health economists.
• Every major health insurance [payer / surrogate endpoint / advisory committee] reviewed the cost-effectiveness data.

Sources: photo by Pixabay on Pexels